Payden & Rygel Elevance Health, Inc. Transaction History

Payden & Rygel

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$446.3 - $502.2 $12.1 Million - $13.6 Million	-27,000 Reduced 39.76%	40,900 $18.8 Million
Q4 2022 Feb 13, 2023	BUY	$465.23 - $546.77 $697,845 - $820,155	1,500 Added 2.26%	67,900 $34.8 Million
Q3 2022 Nov 10, 2022	BUY	$445.98 - $507.0 $12.1 Million - $13.8 Million	27,200 Added 69.39%	66,400 $30.2 Million
Q2 2022 Aug 12, 2022	BUY	$444.32 - $529.84 $15.7 Million - $18.8 Million	35,400 Added 931.58%	39,200 $18.9 Million
Q1 2022 Apr 13, 2022	BUY	$428.44 - $502.48 $814,036 - $954,712	1,900 Added 100.0%	3,800 $1.87 Million
Q4 2021 Feb 11, 2022	SELL	$370.08 - $467.67 $23.4 Million - $29.6 Million	-63,200 Reduced 97.08%	1,900 $881,000
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $71,502 - $79,626	-200 Reduced 0.31%	65,100 $24.3 Million
Q2 2021 Aug 06, 2021	BUY	$352.19 - $401.9 $35,219 - $40,190	100 Added 0.15%	65,300 $24.9 Million
Q1 2021 May 13, 2021	BUY	$287.7 - $371.31 $18.8 Million - $24.2 Million	65,200 New	65,200 $23.4 Million

1,861

198M

1.03M

1.24M

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $96.6B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

Stay updated on Payden & Rygel with notifications on news.